PRINT

Lecture by the President of AMED at the EU Delegation to Japan

27.04.2020

On 27 March, Dr. Makoto Suematsu, President of the Japan Agency for Medical Research and Development (AMED), who is also a key person in the G-7 discussions on research and development actions addressing the COVID-19 outbreak, visited the EU Delegation to Japan to inform EU and its Science and Technology Counsellors about their role in addressing the COVID-19 outbreak and exchanged views on collaboration opportunities.

During his lecture, Dr. Suematsu informed that a  large part of AMED's 2020 supplementary budget, approximately 160 million euro, is likely to be dedicated to research actions addressing COVID-19, possibly jointly with international partners. He highly praised collaboration with the EU under the International ECMO Network (ECMONet), as well as GLoPID-R and EDCTP, and showed interest in exploring further opportunities, such as research on CureVac.

 

PRACTICAL INFORMATION

OVERVIEW
-
Europa house, 4-6-28, Minami-Azabu, Minato-ku, Tokyo, 106-0047